(Q22306221)

8 February 2023

Clara Bouché

1

Clara

Bouché

1 reference

15466941

8 February 2023

Shanti Serdy

series ordinal

2

author given names

Shanti

author last names

Serdy

1 reference

15466941

8 February 2023

Allison B. Goldfine

series ordinal

4

author given names

Allison B

author last names

Goldfine

1 reference

15466941

Self-glucosylation of glycogenin, the initiator of glycogen biosynthesis, involves an inter-subunit reaction

8 February 2023

language of work or name

English

0 references

publication date

October 2004

0 references

published in

Endocrine Reviews

0 references

volume

25

0 references

issue

5

0 references

page(s)

807-830

0 references

cites work

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mechanisms modifying glucose oxidation in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

https://api.crossref.org/works/10.1210%2FER.2003-0026

1 reference

7 January 2021

No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Developmental expression of hexokinase 1 and 3 in rats.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mechanisms of acute and chronic hypoglycemic action of gliclazide.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hepatic sensitivity to insulin: effects of sulfonylurea drugs.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Localization of the type III isozyme of hexokinase at the nuclear periphery

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of the citric acid cycle in mammalian systems

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Relationship between the plasma glucose level and glucose uptake in the conscious dog

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effect of sulfonylureas on hepatic glycogen metabolism: activation of glycogen phosphorylase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence that glucose transport is rate-limiting for in vivo glucose uptake

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Linkage of type 2 diabetes to the glucokinase gene

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The pancreatic beta-cell glucose sensor.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Lipid overload and overflow: metabolic trauma and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Muscle glycogen synthase translocates from the cell nucleus to the cystosol in response to glucose

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glycogenin, the primer of glycogen synthesis, binds to actin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Gliclazide potentiates suppression of hepatic glucose production in non—insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucosamine-6-phosphate synthase--the multi-facets enzyme.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evolution and regulatory role of the hexokinases

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Free fatty acids and pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Novel targets and therapeutic strategies for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The amino-terminal tail of glycogen phosphorylase is a switch for controlling phosphorylase conformation, activation, and response to ligands

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Structural domains that contribute to substrate specificity in facilitated glucose transporters are distinct from those involved in kinetic function: studies with GLUT-1/GLUT-2 chimeras

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Interaction of hexokinase with the outer mitochondrial membrane and a hydrophobic matrix

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glycogen storage diseases

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A nutrient-sensing pathway regulates leptin gene expression in muscle and fat.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Digenic inheritance of severe insulin resistance in a human pedigree

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Antagonistic regulation of the glucose/glucose 6-phosphate cycle by insulin and glucagon in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Radicals and oxidative stress in diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of hexokinase II expression in human skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Liver glucokinase: decreased activity in patients with type II diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Familial hyperinsulinism caused by an activating glucokinase mutation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Short-term regulation of insulin gene transcription by glucose

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Modulation of GLUT1 intrinsic activity in clone 9 cells by inhibition of oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hexokinase II-deficient mice. Prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Dual mechanisms for glucose 6-phosphate inhibition of human brain hexokinase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-a

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A major predisposition locus for severe obesity, at 4p15-p14

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Control of glycogen synthase by hierarchal protein phosphorylation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glycogenin is the priming glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Translocation and aggregation of hepatic glycogen synthase during the fasted-to-refed transition in rats.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Allosteric activators of glucokinase: potential role in diabetes therapy

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

https://api.crossref.org/works/10.1210%2FER.2003-0026

1 reference

7 January 2021

Exercise, glucose transport, and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Novel concepts in insulin regulation of hepatic gluconeogenesis

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of reduced free fatty acid availability on skeletal muscle PDH activation during aerobic exercise. Pyruvate dehydrogenase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Gluconeogenesis in humans with induced hyperlactatemia during low-intensity exercise

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Identification of a novel glucose transporter-like protein-GLUT-12

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Renal Na(+)-glucose cotransporters

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Identification of a biochemical link between energy intake and energy expenditure

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Influence of hyperglycemia on insulin's in vivo effects in type II diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Kinetics of glucose disposal in whole body and across the forearm in man.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Role of the glucosamine pathway in fat-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Exercise training increases the activity of pyruvate dehydrogenase complex in skeletal muscle of diabetic rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic beta-cell line

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The molecular basis of type 1 glycogen storage diseases

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Exercise and Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucokinase gene structure. Functional implications of molecular genetic studies

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hexosamines and insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

New insights into the role and mechanism of glycogen synthase activation by insulin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin-induced hexokinase II expression is reduced in obesity and NIDDM

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Triggering and amplifying pathways of regulation of insulin secretion by glucose

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Mechanism of troglitazone action in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of glucosamine infusion on insulin secretion and insulin action in humans.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Endocrine pancreas plasticity under physiological and pathological conditions

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Troglitazone induces GLUT4 translocation in L6 myotubes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Hexokinase isozyme distribution in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Interaction of insulin and exercise on glucose transport in muscle

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021

Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FER.2003-0026

7 January 2021